BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6133955)

  • 1. Enzymic resolution and binding to rat brain membranes of the glutamic acid agonist alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid.
    Hansen JJ; Lauridsen J; Nielsen E; Krogsgaard-Larsen P
    J Med Chem; 1983 Jun; 26(6):901-3. PubMed ID: 6133955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha-[3H]Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid binding to rat striatal membranes: effects of selective brain lesions.
    Errami M; Nieoullon A
    J Neurochem; 1988 Aug; 51(2):579-86. PubMed ID: 2899136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]AMPA binding to glutamate receptor subpopulations in rat brain.
    Olsen RW; Szamraj O; Houser CR
    Brain Res; 1987 Feb; 402(2):243-54. PubMed ID: 2881601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The binding of [3H]AMPA, a structural analogue of glutamic acid, to rat brain membranes.
    Honoré T; Lauridsen J; Krogsgaard-Larsen P
    J Neurochem; 1982 Jan; 38(1):173-8. PubMed ID: 6125564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of quisqualate recognition sites in rat brain tissue using DL-[3H]alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) and a filtration assay.
    Murphy DE; Snowhill EW; Williams M
    Neurochem Res; 1987 Sep; 12(9):775-81. PubMed ID: 2890112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoradiographic characterization and localization of quisqualate binding sites in rat brain using the antagonist [3H]6-cyano-7-nitroquinoxaline-2,3-dione: comparison with (R,S)-[3H]alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid binding sites.
    Nielsen EO; Drejer J; Cha JH; Young AB; Honoré T
    J Neurochem; 1990 Feb; 54(2):686-95. PubMed ID: 1967632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative autoradiography of binding sites for [3H]AMPA, a structural analogue of glutamic acid.
    Rainbow TC; Wieczorek CM; Halpain S
    Brain Res; 1984 Aug; 309(1):173-7. PubMed ID: 6091846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ibotenic acid analogues. Synthesis, molecular flexibility, and in vitro activity of agonists and antagonists at central glutamic acid receptors.
    Lauridsen J; Honoré T; Krogsgaard-Larsen P
    J Med Chem; 1985 May; 28(5):668-72. PubMed ID: 2859375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excitatory amino acid agonists. Enzymic resolution, X-ray structure, and enantioselective activities of (R)- and (S)-bromohomoibotenic acid.
    Hansen JJ; Nielsen B; Krogsgaard-Larsen P; Brehm L; Nielsen EO; Curtis DR
    J Med Chem; 1989 Oct; 32(10):2254-60. PubMed ID: 2552114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solubilization and partial purification of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid binding sites from rat brain.
    Hunter C; Wheaton KD; Wenthold RJ
    J Neurochem; 1990 Jan; 54(1):118-25. PubMed ID: 2293604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of thiol-reagents on [3H]alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid binding to rat telencephalic membranes.
    Terramani T; Kessler M; Lynch G; Baudry M
    Mol Pharmacol; 1988 Aug; 34(2):117-23. PubMed ID: 2901029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excitatory amino acid receptor ligands. Synthesis and biological activity of 3-isoxazolol amino acids structurally related to homoibotenic acid.
    Christensen IT; Ebert B; Madsen U; Nielsen B; Brehm L; Krogsgaard-Larsen P
    J Med Chem; 1992 Sep; 35(19):3512-9. PubMed ID: 1383544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of excitatory amino acid binding sites during neuritogenesis in the developing rat cerebellum.
    Cambray-Deakin MA; Foster AC; Burgoyne RD
    Brain Res Dev Brain Res; 1990 Jul; 54(2):265-71. PubMed ID: 1975776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of [3H]AMPA binding sites in rat brain as determined by quantitative autoradiography.
    Monaghan DT; Yao D; Cotman CW
    Brain Res; 1984 Dec; 324(1):160-4. PubMed ID: 6097340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamic acid agonists. Stereochemical and conformational studies of DL-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and related compounds.
    Krogsgaard-Larsen P; Hansen JJ; Lauridsen J; Peet MJ; Leah JD; Curtis DR
    Neurosci Lett; 1982 Aug; 31(3):313-7. PubMed ID: 6127659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel class of amino acid antagonists at non-N-methyl-D-aspartic acid excitatory amino acid receptors. Synthesis, in vitro and in vivo pharmacology, and neuroprotection.
    Krogsgaard-Larsen P; Ferkany JW; Nielsen EO; Madsen U; Ebert B; Johansen JS; Diemer NH; Bruhn T; Beattie DT; Curtis DR
    J Med Chem; 1991 Jan; 34(1):123-30. PubMed ID: 1825114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Methyl-D-aspartate and quisqualate/DL-alpha-amino-3-hydroxy-5- methylisoxazole-4-propionic acid receptors: differential regulation by phospholipase C treatment.
    Massicotte G; Kessler M; Lynch G; Baudry M
    Mol Pharmacol; 1990 Feb; 37(2):278-85. PubMed ID: 2154675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional distribution of alpha-[3H]amino-3-hydroxy-5-methylisoxazole-4-propionic acid binding sites in rat brain: effect of chemical modification of SH- groups in tissue sections.
    Baudry M; Monaghan D; Cotman C; Altar CA
    J Neurochem; 1990 May; 54(5):1682-8. PubMed ID: 2157815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in cortical [3H]kainate and alpha-[3H]amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid binding in a spontaneous canine model of chronic hepatic encephalopathy.
    Maddison JE; Watson WE; Dodd PR; Johnston GA
    J Neurochem; 1991 Jun; 56(6):1881-8. PubMed ID: 1673994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiocyanate equally increases affinity for two DL-alpha-amino-3-hydroxy-5-methylisoxazolepropionic acid (AMPA) receptor states.
    Hall RA; Massicotte G; Kessler M; Baudry M; Lynch G
    Mol Pharmacol; 1993 Mar; 43(3):459-64. PubMed ID: 7680752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.